Connecticut CannaTimesFacts first. You decide.

Front Page › Who's Who › Federal

Agency

DEA / federal scheduling

7 stories mention Federal. Mentions are matched automatically from headlines and summaries.

Schedule III Is Nothing to Celebrate

That is the date the United States government was granted U.S. Patent No. 6,630,507 for cannabinoids, formally recognizing them as compounds with medical value, including antioxidant and neuroprotective properties with potential applications in conditions such as Alzheimer’s disease, Parkinson’s disease, and stroke.

Why Federal Rescheduling Fails Connecticut and the Public

Federal officials are once again signaling a shift in cannabis policy — this time through rescheduling marijuana under the federal Controlled Substances Act (CSA). While some national organizations and industry voices are celebrating the move as “progress,” the reality is far less encouraging.